Please enable Javascript!

Press Releases

Results: 1 - 20 of 156
1   2   3  
| Each page: 10 20 30
31. March 2020, Koblenz
Image alt

COVID-19: CompuGroup Medical provides telemonitoring to relieve hospitals

Koblenz. COVID-19 patients who remain in home quarantine after inpatient hospital treatment can be treated further and their vital signs are monitored. For other patients, hospitalization may be reduced or may even be prevented completely. This is ensured by a telemonitoring system that CompuGroup Medical SE (CGM) is currently introducing in Italy via its lately acquired company H&S Qualità nel Software SpA. H&S has more than 20 years of experience in this segment and already several Italian hospitals as users. Subsequently it is planned to roll out the system in Germany and other countries. As part of a monitoring system, the H&S Health Platform enables recording vital parameters wirelessly, transmit them to practitioners and alert them immediately in case of an emergency. The software is a certified medical device and has been in use for many years.

25. March 2020, Koblenz

CompuGroup Medical SE confirms dividend on prior year level

Koblenz. With today's publication of the Annual Report 2019, CompuGroup Medical SE (CGM) announced that the Management Board and Supervisory Board intend to propose to the annual general meeting a dividend of EUR 0.50 per share to be paid, on same level as last year.

13. March 2020, Koblenz
Image alt

Corona virus: Many doctors opt for video consultation

Koblenz. Already 5’000 doctors have decided to register for CLICKDOC VIDEOSPRECHSTUNDE in the context of the current corona virus wave. Since last week, CompuGroup Medical (CGM) has been providing doctors with its video consultation solution free of charge. This enables doctors, practice teams and other patients to escape the risk of infection by patients suspected of being infected with Covid-19 in many cases.

05. March 2020,
Image alt

Telematics Infrastructure: Doctors to test NFDM and eMP

Koblenz. CompuGroup Medical Deutschland AG (CGM) has been installing the necessary components for testing the new applications in the Telematics Infrastructure (TI) since this week. Immediately after installation, the service providers involved were able to start testing the applications Emergency Data Management (Notfalldatenmanagement, NFDM), Electronic Medication Plan (eMP), and Qualified Electronic Signature (QES) in doctor's offices and pharmacies using the KoCoBoxMED+ e-health connector.

12. February 2020, Koblenz
Image alt

CompuGroup Medical SE (CGM) attracts Dirk Wössner as CEO; Frank Gotthardt will join the supervisory board

After 33 successful years at the top of CompuGroup Medical SE (CGM), company founder and eHealth pioneer Frank Gotthardt will hand over the chairmanship of the management board to his successor Dr. Dirk Wössner by the end of the year at the latest.

05. February 2020, Koblenz

CompuGroup Medical to acquire certain Cerner assets in Germany and Spain

CompuGroup Medical SE (CGM), one of the world's leading providers of eHealth solutions, today presented its financial report for the fourth quarter and the full financial year 2019 based on preliminary, unaudited figures.

05. February 2020, Koblenz

CompuGroup Medical grows and expects further increase for 2020

CompuGroup Medical SE (CGM), one of the world's leading providers of eHealth solutions, today presented its financial report for the fourth quarter and the full financial year 2019 based on preliminary, unaudited figures.

08. January 2020, Koblenz / Piacenza (Italy)

CompuGroup Medical SE acquires Italian company H&S Qualità nel Software SpA

Koblenz / Piacenza (Italy), January 08, 2020 – CompuGroup Medical SE (CGM), a leading eHealth company worldwide, concluded a transaction to acquire 100% of H&S Qualità nel Software SpA on January 02, 2020. With the acquisition of the provider of telemedicine solutions and ICT services for domiciliary care providers, CGM is expanding its portfolio to include powerful solutions for health and social-care providers.

27. December 2019, Koblenz
Image alt

CompuGroup Medical acquires EPSILOG SAS

Koblenz, December 27 2019 – CompuGroup Medical SE (CGM) is acquiring 100 % of EPSILOG SAS (EPSILOG), based in Castries, France. Today, CompuGroup Medical SE, as purchaser, and Hevanance S.à r.l. and Goodwill Systems S.à r.l., as sellers, have signed an agreement regarding the sale and purchase of 100 % of the shares in MB Invest SAS which is the sole owner of EPSILOG SAS. EPSILOG's key product is VEGA, an ambulatory information system with a leading position in French healthcare IT for psychotherapists and nurses. CompuGroup Medical is thereby strengthening its position in France, complementing its portfolio to address new customer groups in France. The agreed purchase price for EPSILOG amounts to EUR 72 million and is subject to further adjustments post-closing. In 2018, EPSILOG SAS had revenues of more than EUR 14 million and an EBITDA of approximately EUR 5 million with 44.000 customers.

15. November 2019, Koblenz
Image alt

First eHealth connector receives approval for use in telematics infrastructure

CompuGroup Medical Deutschland AG (CGM) is the first manufacturer to receive gematik's approval for the use of an eHealth connector, the KoCoBox MED, in telematics infrastructure (TI). For the first time in medical care, new eHealth applications, such as emergency data management (Notfalldatenmanagement, NFDM) and the electronic medication plan (Elektronischer Medikationsplan, eMP), can now be stored on the electronic health card (Elektronische Gesundheitskarte, eGK). With this approval, CGM once again confirms its responsibility as market leader and sets another important milestone in the digitization of the healthcare system.

07. November 2019, Koblenz

CompuGroup Medical grows in third quarter 2019 in all segments, guidance confirmed

CompuGroup Medical SE, one of the leading providers of eHealth solutions, looks back on a successful third quarter of 2019.

15. October 2019, Koblenz
Image alt

Dr. Eckart Pech joins Management Board of CompuGroup Medical SE

Dr. Eckart Pech will join the Management Board of CompuGroup Medical SE on November 1, 2019, and will lead the newly created Consumer and Health Management Information Systems segment. The Koblenz-based company, one of the world's largest providers of eHealth solutions, aims to further strengthen its role as a driving force for connectivity within the healthcare sector.

15. October 2019, Koblenz

Change in the Management Board of CompuGroup Medical

Uwe Eibich, member of the Management Board of CompuGroup Medical SE and member of the Management Board of CGM Deutschland AG, will resign from office at his request with effect from 31 December 2019.

05. September 2019, Koblenz

CompuGroup Medical SE promoted to MDAX

CompuGroup Medical SE shares will in future be listed in the MDAX, as Deutsche Börse announced. The change in the index composition will take effect on September 23. The company meets the two required quantitative admission criteria of market capitalization and trading volume.

08. August 2019, Koblenz

CompuGroup Medical SE reaffirms guidance for 2019

CompuGroup Medical SE (CGM) has reported its financial results for the second quarter of 2019 today. Consolidated revenue was around EUR 187 million, just slightly below the exceptional quarter of the previous year, which was marked by the peak of the rollout of the telematics infrastructure (TI). Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) on a pro forma basis amounted to EUR 44 million in the second quarter of 2019, with an operating margin of 24%. The guidance for the full year 2019 with revenues in the amount of EUR 720 to 750 million and an EBITDA of EUR 190 to 205 million is reaffirmed.

06. August 2019, Koblenz
Image alt

CGM strengthens Investor Relations: Claudia Thomé to join as new Head of Investor Relations

As of September 1, 2019, Claudia Thomé, currently Co-Head of Investor Relations at Axel Springer SE, will take on the newly created position Head of Investor Relations at CompuGroup Medical SE and report to CFO Michael Rauch.

04. July 2019, Koblenz

More than every second measles infection occurs in adults – doctor's practices provide help

Fewer measles cases and higher vaccination rates in adults thanks to better consultation in the doctor's office: Intelligent software automatically alerts family doctors to recommended measles vaccinations during the health check-up of adult patients between 18 and 49 years of age. The system also points out their importance: More than half of all measles cases in Germany occur in adults. This functionality is now available to every third family practice in Germany at no additional cost.

28. June 2019, Milan

Italy: Electronic veterinary prescription is coming

The WINGESFAR pharmacy management system, the software leader of CompuGroup Medical (CGM) on the Italian pharmacy market, now enables efficiency and simplicity in the administration of electronic veterinary prescriptions. An update makes it possible to process the electronic veterinary prescription in the same way as the electronic prescription of medicinal products for human use.

28. May 2019, Koblenz

CompuGroup Medical Receives a Major Order for its Hospital Information System

The Niederösterreichische Landeskliniken-Holding (Lower Austrian Regional Hospital Holding – NÖLKH) has chosen the CGM CLINICAL Hospital Information System from CompuGroup Medical (CGM) as the basis for a harmonized and centralized information system group-wide in medicine and care.

06. May 2019, Koblenz

CompuGroup Medical SE Reports Results for First Quarter of 2019

CompuGroup Medical SE (CGM) today reported its financial results for the first quarter of 2019. The Koblenz-based company, one of the world's leading providers of eHealth solutions, generated a revenue of EUR 175 million compared to EUR 166 million in the same period of the previous year. Also favored by regulatory accounting changes, consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA) and operating margin both rose to EUR 50 million and 28 percent in the first quarter of 2019, compared with EUR 39 million and 23 percent in the same period of the previous year.

Results: 1 - 20 of 156
1   2   3  
| Each page: 10 20 30
 
More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More More